Neurofeedback Market, by Product (Amplifiers, Electrodes or Sensors, and Computer Software), by System (Frequency/Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Neurofeedback is a non-invasive treatment that encourages the brain to develop healthier patterns of activity. The goal of treatment is not only to change how one think and feel, but also to change brain on a biological level for better functioning. Neurofeedback is a method that assists subjects to control their brain waves consciously. While getting neurofeedback, electroencephalography (EEG) is actually being recorded. Then, its many components are separated and provided to participants via an online feedback loop as audio, video, or a combination of both. Electrical impulses called brain waves are employed by brain cells as a form of communication. Each brain wave has two distinct properties: frequency, or how quickly it moves, and amplitude, or how high it rises and falls. Faster brain waves are typically related with focus, thinking, and consciousness, while slower brain waves are typically associated with relaxation, meditation, and deep sleep. Neurofeedback is frequently used to treat brain wave dysregulation brought on by traumatic situations. For social and emotional deficiencies such conduct disorder, autism, and reactive attachment disorder, right-side training is also used.
A complementary therapy for psychiatric conditions such as attention-deficit/hyperactivity disorder, anxiety disorder, posttraumatic stress disorder, phobic disorder, obsessive-compulsive disorder, bipolar disorder, depression and affective disorders, autism, and addictive disorders, neurofeedback is also known as electroencephalogram (EEG) biofeedback or neurotherapy.
Market Dynamics
Increasing prevalence of mental disorders such as schizophrenia, anxiety and others is expected to drive the growth of the global neurofeedback market over the forecast period. For instance, data published on 10 January 2022, by WHO, stated that every year, schizophrenia affects around 24 million people or 1 in 300 people (0.32%) worldwide.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook